Guo, Caixia <br/><br/>
Apelin promotes diabetic nephropathy by inducing podocyte dysfunction via inhibiting proteasome activities.  [electronic resource] 

 -  Journal of cellular and molecular medicine  Sep 2015 
 - 2273-85 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1582-4934 
<br/><br/><label>Standard No.: </label>10.1111/jcmm.12619  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Albumins--metabolism<br/>Animals<br/>Apelin Receptors<br/>Basement Membrane--drug effects<br/>Cell Membrane Permeability--drug effects<br/>Creatinine--metabolism<br/>Cyclic AMP--pharmacology<br/>Diabetes Mellitus, Type 2--pathology<br/>Diabetic Nephropathies--pathology<br/>Endoplasmic Reticulum Stress--drug effects<br/>Female<br/>Glucose--pharmacology<br/>Humans<br/>Intercellular Signaling Peptides and Proteins--adverse effects<br/>Iridoid Glucosides<br/>Iridoids--pharmacology<br/>Kidney--drug effects<br/>Kidney Function Tests<br/>Male<br/>Mice, Inbred C57BL<br/>Middle Aged<br/>Podocytes--drug effects<br/>Proteasome Endopeptidase Complex--metabolism<br/>Proteasome Inhibitors--pharmacology<br/>Receptors, G-Protein-Coupled--metabolism